Natural Product ID:   | NPC107919 |
Common Name:   | Aphidicolin |
IUPAC Name:   | |
Synonyms:   | Aphidicolin |
Molecular Formula:   | C20H34O4 |
Standard InCHIKey:   | NOFOAYPPHIUXJR-APNQCZIXSA-N |
Standard InCHI:   | InChI=1S/C20H34O4/c1-17(11-21)15-4-3-13-9-14-10-19(13,7-8-20(14,24)12-22)18(15,2)6-5-16(17)23/h13-16,21-24H,3-12H2,1-2H3/t13-,14+,15-,16+,17-,18-,19-,20-/m0/s1 |
Canonical SMILES:   | OC[C@@]1(O)CC[C@]23C[C@H]1C[C@@H]2CC[C@@H]1[C@]3(C)CC[C@H]([C@@]1(C)CO)O |
First Find Year:   | |
Max Developmental Stage:   | |
Synthetic Gene Cluster:   | BGC0000676 ; |
Target ID | Target Type | Target Name | Target Organism | Activity Type | Activity Relation | Value | Unit | Reference |
---|---|---|---|---|---|---|---|---|
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | IC50 | = | 0.2 | ug/ml | 10956199 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | IC50 | = | 590 | nM | 10956199 |
NPT4228 | Individual Protein | Human herpesvirus 6 DNA polymerase | Human herpesvirus 6A (strain Uganda-1102) (HHV-6 variant A) (Human Blymphotropic virus) | IC50 | = | 400 | nM | 10999475 |
NPT2215 | Individual Protein | DNA polymerase alpha subunit | Homo sapiens | IC50 | = | 3000 | nM | 10999475 |
NPT165 | Cell Line | HeLa | Homo sapiens | Inhibition | = | 84 | % | 3806587 |
NPT165 | Cell Line | HeLa | Homo sapiens | Inhibition | = | 0 | % | 3806587 |
NPT317 | Uncleic Acid | Nucleic Acid | Inhibition | = | 50 | % | 6090666 | |
NPT2215 | Individual Protein | DNA polymerase alpha subunit | Homo sapiens | EC50 | = | 2000 | nM | 8246219 |
NPT317 | Uncleic Acid | Nucleic Acid | EC50 | = | 5000 | nM | 8246219 | |
NPT4229 | Individual Protein | Human herpesvirus 5 DNA polymerase | Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5) | IC50 | = | 400 | nM | 16134946 |
NPT4230 | Individual Protein | Human herpesvirus 1 DNA polymerase | Herpes simplex virus (type 1 / strain 17) | IC50 | = | 500 | nM | 16134946 |
NPT4231 | Individual Protein | DNA polymerase | Varicella-zoster virus (strain Dumas) (HHV-3) (Human herpesvirus 3) | IC50 | = | 600 | nM | 16134946 |
NPT2215 | Individual Protein | DNA polymerase alpha subunit | Homo sapiens | IC50 | = | 2600 | nM | 16134946 |
NPT4231 | Individual Protein | DNA polymerase | Varicella-zoster virus (strain Dumas) (HHV-3) (Human herpesvirus 3) | IC50 | = | 2600 | nM | 16134946 |
NPT4232 | Individual Protein | DNA polymerase delta subunit 1 | Homo sapiens | IC50 | > | 40000 | nM | 16134946 |
NPT2 | Others | Unspecified | IC50 | = | 400 | nM | 17513108 | |
NPT2 | Others | Unspecified | IC50 | = | 500 | nM | 17513108 | |
NPT2 | Others | Unspecified | IC50 | = | 600 | nM | 17513108 | |
NPT2 | Others | Unspecified | IC50 | = | 2600 | nM | 17513108 | |
NPT4229 | Individual Protein | Human herpesvirus 5 DNA polymerase | Human cytomegalovirus (strain AD169) (HHV-5) (Human herpesvirus 5) | IC50 | = | 487 | nM | 17434304 |
NPT2 | Others | Unspecified | IC50 | = | 438 | nM | 17434304 | |
NPT2 | Others | Unspecified | IC50 | = | 473 | nM | 17434304 | |
NPT2 | Others | Unspecified | IC50 | = | 2600 | nM | 17434304 | |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 73.06 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 216.53 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 275.5 | % | 18024584 |
NPT1892 | Cell Line | H4 | Rattus norvegicus | Activity | = | 350.13 | % | 18024584 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | Activity | = | 100 | % | 1667410 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | CC50 | = | 200 | ug/ml | 1667410 |
NPT168 | Cell Line | P388 | Mus musculus | ED50 | = | 0.13 | ug/ml | 6434698 |
NPT2 | Others | Unspecified | IC50 | = | 2600 | nM | 18595689 | |
NPT2 | Others | Unspecified | IC50 | = | 473 | nM | 18595689 | |
NPT4233 | Individual Protein | DNA polymerase catalytic subunit | Human herpesvirus 1 (strain KOS) (HHV-1) (Human herpes simplex virus1) | IC50 | = | 438 | nM | 18595689 |
NPT2 | Others | Unspecified | IC50 | = | 487 | nM | 18595689 | |
NPT2 | Others | Unspecified | IC50 | = | 487 | nM | 20167488 | |
NPT2 | Others | Unspecified | IC50 | = | 473 | nM | 20167488 | |
NPT2 | Others | Unspecified | IC50 | = | 487 | nM | 20403696 | |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | IC50 | = | 438 | nM | 20403696 |
NPT2 | Others | Unspecified | IC50 | = | 473 | nM | 20403696 | |
NPT2215 | Individual Protein | DNA polymerase alpha subunit | Homo sapiens | IC50 | = | 2600 | nM | 20403696 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | Activity | = | 100 | % | 20691339 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | IC50 | = | 580 | nM | 20691339 |
NPT483 | Individual Protein | Prelamin-A/C | Homo sapiens | Potency | = | 794.3 | nM | PubChem BioAssay data set |
NPT47 | Individual Protein | ATP-dependent DNA helicase Q1 | Homo sapiens | Potency | = | 5623.4 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 794.3 | nM | PubChem BioAssay data set |
NPT93 | Individual Protein | Survival motor neuron protein | Homo sapiens | Potency | = | 2238.7 | nM | PubChem BioAssay data set |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | > | 150000 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | EC50 | = | 1731 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | EC50 | = | 839 | nM | PubChem BioAssay data set | |
NPT211 | Individual Protein | Hypoxia-inducible factor 1 alpha | Homo sapiens | Potency | = | 1995.3 | nM | PubChem BioAssay data set |
NPT2 | Others | Unspecified | Potency | = | 206 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | EC50 | > | 150000 | nM | PubChem BioAssay data set | |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | = | 38639 | nM | PubChem BioAssay data set |
NPT1160 | Cell Line | BJ | Homo sapiens | EC50 | = | 28620 | nM | PubChem BioAssay data set |
NPT1197 | Individual Protein | Huntingtin | Homo sapiens | Potency | = | 631 | nM | PubChem BioAssay data set |
NPT2215 | Individual Protein | DNA polymerase alpha subunit | Homo sapiens | IC50 | = | 16000 | nM | 20516278 |
NPT59 | Individual Protein | DNA polymerase beta | Homo sapiens | IC50 | > | 100000 | nM | 20516278 |
NPT4234 | Individual Protein | DNA polymerase gamma subunit 1 | Homo sapiens | IC50 | > | 100000 | nM | 20516278 |
NPT5 | Individual Protein | Histone-lysine N-methyltransferase, H3 lysine-9 specific 3 | Homo sapiens | Potency | 6309.6 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 585.8 | nM | PubChem BioAssay data set | |
NPT6 | Organism | Plasmodium falciparum | Plasmodium falciparum | Potency | 522.1 | nM | PubChem BioAssay data set | |
NPT71 | Cell Line | HEK293 | Homo sapiens | Potency | 730.8 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | Potency | 517.4 | nM | PubChem BioAssay data set | ||
NPT66 | Individual Protein | Acetylcholinesterase | Electrophorus electricus | Inhibition | = | 8.45 | % | 23062825 |
NPT67 | Individual Protein | Cholinesterase | Equus caballus | Inhibition | = | 13.47 | % | 23062825 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | Activity | = | 100 | % | 10.1007/s00044-011-9753-7 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | CD50 | = | 20 | ug/ml | 10.1007/s00044-011-9753-7 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | MIC | = | 5 | ug/ml | 10.1007/s00044-011-9753-7 |
NPT189 | Cell Line | Vero | Chlorocebus aethiops | Activity | = | 0.01 | ug/ml | 10.1007/s00044-010-9420-4 |
NPT190 | Organism | Human herpesvirus 1 | Human herpesvirus 1 | Activity | = | 100 | % | 10.1007/s00044-010-9420-4 |
NPT2 | Others | Unspecified | Potency | 131 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 104.1 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 39810.7 | nM | PubChem BioAssay data set | ||
NPT2 | Others | Unspecified | Potency | 31622.8 | nM | PubChem BioAssay data set | ||
NPT49 | Individual Protein | DNA-(apurinic or apyrimidinic site) lyase | Homo sapiens | Potency | 39810.7 | nM | PubChem BioAssay data set | |
NPT2 | Others | Unspecified | IC50 | = | 7170 | nM | 10.1039/C3MD00014A | |
NPT2 | Others | Unspecified | IC50 | = | 1960 | nM | 10.1039/C3MD00014A | |
NPT2 | Others | Unspecified | IC50 | = | 19600 | nM | 24926891 | |
NPT2216 | Individual Protein | DNA polymerase beta | Rattus norvegicus | IC50 | > | 100000 | nM | 24926891 |
NPT393 | Cell Line | HCT-116 | Homo sapiens | IC50 | = | 9000 | nM | 24926891 |
NPT2 | Others | Unspecified | EC50 | 136 | nM | PubChem BioAssay data set |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient
●  The left chart: Distribution of similarity level between NPC107919 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Natural Product ID |
---|---|---|
0.9394 | High Similarity | NPC470830 |
0.9394 | High Similarity | NPC299948 |
0.9394 | High Similarity | NPC241085 |
0.9275 | High Similarity | NPC243027 |
0.9275 | High Similarity | NPC158208 |
0.9275 | High Similarity | NPC196136 |
0.9275 | High Similarity | NPC317242 |
0.9265 | High Similarity | NPC153719 |
0.9254 | High Similarity | NPC231945 |
0.9143 | High Similarity | NPC163597 |
0.913 | High Similarity | NPC192501 |
0.913 | High Similarity | NPC228994 |
0.913 | High Similarity | NPC10476 |
0.9118 | High Similarity | NPC157777 |
0.9118 | High Similarity | NPC131506 |
0.9104 | High Similarity | NPC66407 |
0.9091 | High Similarity | NPC473230 |
0.9091 | High Similarity | NPC48079 |
0.9091 | High Similarity | NPC475884 |
0.9091 | High Similarity | NPC63190 |
0.9077 | High Similarity | NPC472946 |
0.9062 | High Similarity | NPC114891 |
0.9014 | High Similarity | NPC192046 |
0.9014 | High Similarity | NPC302578 |
0.9014 | High Similarity | NPC128951 |
0.9014 | High Similarity | NPC105208 |
0.9014 | High Similarity | NPC11907 |
0.9014 | High Similarity | NPC185915 |
0.9014 | High Similarity | NPC133596 |
0.9014 | High Similarity | NPC477227 |
0.8986 | High Similarity | NPC472341 |
0.8986 | High Similarity | NPC470610 |
0.8986 | High Similarity | NPC473238 |
0.8971 | High Similarity | NPC192192 |
0.8955 | High Similarity | NPC472741 |
0.8939 | High Similarity | NPC142712 |
0.8906 | High Similarity | NPC71460 |
0.8906 | High Similarity | NPC148174 |
0.8906 | High Similarity | NPC218585 |
0.8889 | High Similarity | NPC67657 |
0.8889 | High Similarity | NPC18857 |
0.8889 | High Similarity | NPC147993 |
0.8873 | High Similarity | NPC470145 |
0.8857 | High Similarity | NPC304499 |
0.8857 | High Similarity | NPC48795 |
0.8841 | High Similarity | NPC157422 |
0.8841 | High Similarity | NPC470071 |
0.8841 | High Similarity | NPC252182 |
0.8841 | High Similarity | NPC1340 |
0.8841 | High Similarity | NPC100586 |
0.8841 | High Similarity | NPC127094 |
0.8841 | High Similarity | NPC187471 |
0.8841 | High Similarity | NPC109457 |
0.8824 | High Similarity | NPC99264 |
0.8824 | High Similarity | NPC129829 |
0.8824 | High Similarity | NPC254037 |
0.8824 | High Similarity | NPC470833 |
0.8788 | High Similarity | NPC473276 |
0.8788 | High Similarity | NPC474380 |
0.8788 | High Similarity | NPC243469 |
0.8788 | High Similarity | NPC41577 |
0.8788 | High Similarity | NPC260116 |
0.8788 | High Similarity | NPC190827 |
0.8788 | High Similarity | NPC475943 |
0.8767 | High Similarity | NPC477282 |
0.8767 | High Similarity | NPC287452 |
0.8767 | High Similarity | NPC81074 |
0.875 | High Similarity | NPC64081 |
0.875 | High Similarity | NPC474574 |
0.8732 | High Similarity | NPC270306 |
0.8732 | High Similarity | NPC231680 |
0.8732 | High Similarity | NPC91387 |
0.8696 | High Similarity | NPC251201 |
0.8696 | High Similarity | NPC63588 |
0.8696 | High Similarity | NPC232925 |
0.8696 | High Similarity | NPC282454 |
0.8657 | High Similarity | NPC44122 |
0.8636 | High Similarity | NPC159654 |
0.8636 | High Similarity | NPC167995 |
0.8636 | High Similarity | NPC118937 |
0.8636 | High Similarity | NPC281540 |
0.8636 | High Similarity | NPC69149 |
0.8611 | High Similarity | NPC477602 |
0.8611 | High Similarity | NPC91573 |
0.8611 | High Similarity | NPC477601 |
0.8611 | High Similarity | NPC473916 |
0.8592 | High Similarity | NPC478130 |
0.8571 | High Similarity | NPC473279 |
0.8571 | High Similarity | NPC127283 |
0.8571 | High Similarity | NPC478103 |
0.8571 | High Similarity | NPC195530 |
0.8571 | High Similarity | NPC8004 |
0.8551 | High Similarity | NPC477820 |
0.8438 | Intermediate Similarity | NPC476735 |
0.8421 | Intermediate Similarity | NPC60018 |
0.8421 | Intermediate Similarity | NPC154043 |
0.8421 | Intermediate Similarity | NPC202688 |
0.8421 | Intermediate Similarity | NPC475388 |
0.8406 | Intermediate Similarity | NPC474756 |
0.8406 | Intermediate Similarity | NPC475893 |
0.84 | Intermediate Similarity | NPC16449 |
0.8333 | Intermediate Similarity | NPC477508 |
0.8333 | Intermediate Similarity | NPC95804 |
0.8333 | Intermediate Similarity | NPC185547 |
0.8312 | Intermediate Similarity | NPC478054 |
0.8312 | Intermediate Similarity | NPC85095 |
0.8312 | Intermediate Similarity | NPC211135 |
0.8312 | Intermediate Similarity | NPC216420 |
0.8289 | Intermediate Similarity | NPC12933 |
0.8281 | Intermediate Similarity | NPC135438 |
0.8267 | Intermediate Similarity | NPC269333 |
0.8261 | Intermediate Similarity | NPC204233 |
0.8243 | Intermediate Similarity | NPC171658 |
0.8243 | Intermediate Similarity | NPC476233 |
0.8243 | Intermediate Similarity | NPC264602 |
0.8235 | Intermediate Similarity | NPC80463 |
0.8219 | Intermediate Similarity | NPC3403 |
0.8205 | Intermediate Similarity | NPC320824 |
0.8194 | Intermediate Similarity | NPC232112 |
0.8182 | Intermediate Similarity | NPC317066 |
0.8182 | Intermediate Similarity | NPC30166 |
0.8158 | Intermediate Similarity | NPC13554 |
0.8154 | Intermediate Similarity | NPC47663 |
0.8133 | Intermediate Similarity | NPC301707 |
0.8133 | Intermediate Similarity | NPC31828 |
0.8133 | Intermediate Similarity | NPC102708 |
0.8133 | Intermediate Similarity | NPC471769 |
0.8108 | Intermediate Similarity | NPC93662 |
0.8108 | Intermediate Similarity | NPC4209 |
0.8108 | Intermediate Similarity | NPC278091 |
0.8108 | Intermediate Similarity | NPC78067 |
0.8101 | Intermediate Similarity | NPC266651 |
0.8101 | Intermediate Similarity | NPC290612 |
0.8082 | Intermediate Similarity | NPC472945 |
0.8082 | Intermediate Similarity | NPC472944 |
0.8082 | Intermediate Similarity | NPC475458 |
0.8077 | Intermediate Similarity | NPC470070 |
0.8077 | Intermediate Similarity | NPC207013 |
0.8077 | Intermediate Similarity | NPC111582 |
0.8077 | Intermediate Similarity | NPC477285 |
0.8056 | Intermediate Similarity | NPC111234 |
0.8056 | Intermediate Similarity | NPC156277 |
0.8056 | Intermediate Similarity | NPC320549 |
0.8056 | Intermediate Similarity | NPC151018 |
0.8056 | Intermediate Similarity | NPC58057 |
0.8052 | Intermediate Similarity | NPC190940 |
0.803 | Intermediate Similarity | NPC95958 |
0.8026 | Intermediate Similarity | NPC220379 |
0.8 | Intermediate Similarity | NPC475172 |
0.8 | Intermediate Similarity | NPC236588 |
0.8 | Intermediate Similarity | NPC23884 |
0.8 | Intermediate Similarity | NPC317913 |
0.8 | Intermediate Similarity | NPC155531 |
0.8 | Intermediate Similarity | NPC215968 |
0.8 | Intermediate Similarity | NPC212453 |
0.8 | Intermediate Similarity | NPC207010 |
0.8 | Intermediate Similarity | NPC475031 |
0.8 | Intermediate Similarity | NPC121981 |
0.7975 | Intermediate Similarity | NPC255882 |
0.7973 | Intermediate Similarity | NPC195155 |
0.7973 | Intermediate Similarity | NPC185536 |
0.7973 | Intermediate Similarity | NPC472952 |
0.7973 | Intermediate Similarity | NPC104387 |
0.7973 | Intermediate Similarity | NPC212879 |
0.7973 | Intermediate Similarity | NPC231256 |
0.7973 | Intermediate Similarity | NPC230704 |
0.7973 | Intermediate Similarity | NPC174964 |
0.7973 | Intermediate Similarity | NPC97534 |
0.7973 | Intermediate Similarity | NPC139765 |
0.7973 | Intermediate Similarity | NPC273366 |
0.7973 | Intermediate Similarity | NPC472950 |
0.7973 | Intermediate Similarity | NPC240235 |
0.7973 | Intermediate Similarity | NPC70982 |
0.7973 | Intermediate Similarity | NPC178383 |
0.7973 | Intermediate Similarity | NPC212733 |
0.7973 | Intermediate Similarity | NPC131584 |
0.7971 | Intermediate Similarity | NPC477603 |
0.7949 | Intermediate Similarity | NPC286719 |
0.7949 | Intermediate Similarity | NPC121121 |
0.7949 | Intermediate Similarity | NPC477286 |
0.7949 | Intermediate Similarity | NPC477599 |
0.7945 | Intermediate Similarity | NPC253805 |
0.7941 | Intermediate Similarity | NPC209686 |
0.7941 | Intermediate Similarity | NPC292419 |
0.7941 | Intermediate Similarity | NPC249078 |
0.7941 | Intermediate Similarity | NPC290791 |
0.7941 | Intermediate Similarity | NPC236099 |
0.7922 | Intermediate Similarity | NPC102253 |
0.7922 | Intermediate Similarity | NPC322313 |
0.7922 | Intermediate Similarity | NPC470609 |
0.7922 | Intermediate Similarity | NPC22403 |
0.7922 | Intermediate Similarity | NPC236237 |
0.7917 | Intermediate Similarity | NPC45296 |
0.7901 | Intermediate Similarity | NPC210658 |
0.7901 | Intermediate Similarity | NPC477600 |
0.7901 | Intermediate Similarity | NPC263802 |
0.7901 | Intermediate Similarity | NPC43912 |
0.7901 | Intermediate Similarity | NPC140446 |
0.7901 | Intermediate Similarity | NPC161928 |
0.7901 | Intermediate Similarity | NPC202937 |
Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.
●  The left chart: Distribution of similarity level between NPC107919 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).
Similarity Score | Similarity Level | Drug ID | Developmental Stage |
---|---|---|---|
1.0 | High Similarity | NPD4267 | Clinical (unspecified phase) |
0.8429 | Intermediate Similarity | NPD4787 | Phase 1 |
0.8108 | Intermediate Similarity | NPD6117 | Approved |
0.8056 | Intermediate Similarity | NPD4809 | Clinical (unspecified phase) |
0.8056 | Intermediate Similarity | NPD4808 | Clinical (unspecified phase) |
0.8 | Intermediate Similarity | NPD6116 | Phase 1 |
0.7922 | Intermediate Similarity | NPD7525 | Registered |
0.7895 | Intermediate Similarity | NPD6697 | Approved |
0.7895 | Intermediate Similarity | NPD6118 | Approved |
0.7895 | Intermediate Similarity | NPD6115 | Approved |
0.7895 | Intermediate Similarity | NPD6114 | Approved |
0.7838 | Intermediate Similarity | NPD6113 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD3700 | Clinical (unspecified phase) |
0.7778 | Intermediate Similarity | NPD3699 | Clinical (unspecified phase) |
0.7639 | Intermediate Similarity | NPD5361 | Clinical (unspecified phase) |
0.7639 | Intermediate Similarity | NPD5360 | Phase 3 |
0.75 | Intermediate Similarity | NPD3703 | Phase 2 |
0.7432 | Intermediate Similarity | NPD4244 | Approved |
0.7432 | Intermediate Similarity | NPD4245 | Approved |
0.7432 | Intermediate Similarity | NPD4789 | Approved |
0.7297 | Intermediate Similarity | NPD3698 | Phase 2 |
0.725 | Intermediate Similarity | NPD6928 | Phase 2 |
0.7222 | Intermediate Similarity | NPD3171 | Clinical (unspecified phase) |
0.7105 | Intermediate Similarity | NPD4758 | Discontinued |
0.7051 | Intermediate Similarity | NPD7339 | Approved |
0.7051 | Intermediate Similarity | NPD6942 | Approved |
0.7045 | Intermediate Similarity | NPD8171 | Discontinued |
0.7024 | Intermediate Similarity | NPD7520 | Clinical (unspecified phase) |
0.7 | Intermediate Similarity | NPD5364 | Discontinued |
0.7 | Intermediate Similarity | NPD3671 | Phase 1 |
0.6962 | Remote Similarity | NPD6933 | Approved |
0.6933 | Remote Similarity | NPD6705 | Phase 1 |
0.6914 | Remote Similarity | NPD7645 | Phase 2 |
0.6883 | Remote Similarity | NPD6081 | Approved |
0.6849 | Remote Similarity | NPD371 | Approved |
0.6829 | Remote Similarity | NPD4748 | Discontinued |
0.6818 | Remote Similarity | NPD6701 | Clinical (unspecified phase) |
0.6818 | Remote Similarity | NPD6700 | Approved |
0.675 | Remote Similarity | NPD3701 | Clinical (unspecified phase) |
0.6742 | Remote Similarity | NPD6703 | Approved |
0.6742 | Remote Similarity | NPD6702 | Approved |
0.6719 | Remote Similarity | NPD385 | Approved |
0.6719 | Remote Similarity | NPD384 | Approved |
0.6709 | Remote Similarity | NPD6924 | Approved |
0.6709 | Remote Similarity | NPD6926 | Approved |
0.6667 | Remote Similarity | NPD4224 | Phase 2 |
0.6625 | Remote Similarity | NPD3702 | Approved |
0.6588 | Remote Similarity | NPD4788 | Approved |
0.6556 | Remote Similarity | NPD8034 | Phase 2 |
0.6556 | Remote Similarity | NPD8035 | Phase 2 |
0.6517 | Remote Similarity | NPD5328 | Approved |
0.6512 | Remote Similarity | NPD4786 | Approved |
0.6477 | Remote Similarity | NPD7524 | Approved |
0.6456 | Remote Similarity | NPD4243 | Approved |
0.6456 | Remote Similarity | NPD5777 | Approved |
0.6429 | Remote Similarity | NPD6931 | Approved |
0.6429 | Remote Similarity | NPD6930 | Phase 2 |
0.6395 | Remote Similarity | NPD6695 | Phase 3 |
0.6383 | Remote Similarity | NPD7920 | Phase 3 |
0.6383 | Remote Similarity | NPD4755 | Approved |
0.6383 | Remote Similarity | NPD7919 | Phase 3 |
0.6374 | Remote Similarity | NPD6079 | Approved |
0.6364 | Remote Similarity | NPD3618 | Phase 1 |
0.6327 | Remote Similarity | NPD8170 | Clinical (unspecified phase) |
0.6322 | Remote Similarity | NPD7338 | Clinical (unspecified phase) |
0.6316 | Remote Similarity | NPD8088 | Phase 1 |
0.631 | Remote Similarity | NPD6929 | Approved |
0.6304 | Remote Similarity | NPD4202 | Approved |
0.6296 | Remote Similarity | NPD4784 | Approved |
0.6296 | Remote Similarity | NPD4785 | Approved |
0.6292 | Remote Similarity | NPD4751 | Clinical (unspecified phase) |
0.6279 | Remote Similarity | NPD3667 | Approved |
0.6265 | Remote Similarity | NPD6932 | Approved |
0.625 | Remote Similarity | NPD5286 | Approved |
0.625 | Remote Similarity | NPD7152 | Approved |
0.625 | Remote Similarity | NPD7151 | Approved |
0.625 | Remote Similarity | NPD5285 | Approved |
0.625 | Remote Similarity | NPD4696 | Approved |
0.625 | Remote Similarity | NPD7150 | Approved |
0.625 | Remote Similarity | NPD8418 | Phase 2 |
0.625 | Remote Similarity | NPD4700 | Approved |
0.6235 | Remote Similarity | NPD7509 | Discontinued |
0.6203 | Remote Similarity | NPD6922 | Approved |
0.6203 | Remote Similarity | NPD6923 | Approved |
0.6186 | Remote Similarity | NPD4159 | Approved |
0.618 | Remote Similarity | NPD8308 | Discontinued |
0.617 | Remote Similarity | NPD7991 | Discontinued |
0.6154 | Remote Similarity | NPD4753 | Phase 2 |
0.6146 | Remote Similarity | NPD7638 | Approved |
0.6125 | Remote Similarity | NPD7144 | Approved |
0.6125 | Remote Similarity | NPD7143 | Approved |
0.6122 | Remote Similarity | NPD5224 | Approved |
0.6122 | Remote Similarity | NPD5211 | Phase 2 |
0.6122 | Remote Similarity | NPD4633 | Approved |
0.6122 | Remote Similarity | NPD5226 | Approved |
0.6122 | Remote Similarity | NPD5225 | Approved |
0.6118 | Remote Similarity | NPD6683 | Phase 2 |
0.6111 | Remote Similarity | NPD7750 | Discontinued |
0.6105 | Remote Similarity | NPD5220 | Clinical (unspecified phase) |
0.6105 | Remote Similarity | NPD5222 | Approved |
0.6105 | Remote Similarity | NPD5221 | Approved |
0.6105 | Remote Similarity | NPD4697 | Phase 3 |
0.61 | Remote Similarity | NPD5739 | Approved |
0.61 | Remote Similarity | NPD6402 | Approved |
0.61 | Remote Similarity | NPD7128 | Approved |
0.61 | Remote Similarity | NPD6675 | Approved |
0.6098 | Remote Similarity | NPD1810 | Approved |
0.6098 | Remote Similarity | NPD1811 | Approved |
0.6082 | Remote Similarity | NPD7640 | Approved |
0.6082 | Remote Similarity | NPD7639 | Approved |
0.6071 | Remote Similarity | NPD5776 | Phase 2 |
0.6071 | Remote Similarity | NPD6925 | Approved |
0.6067 | Remote Similarity | NPD6893 | Approved |
0.6061 | Remote Similarity | NPD5174 | Approved |
0.6061 | Remote Similarity | NPD386 | Approved |
0.6061 | Remote Similarity | NPD388 | Approved |
0.6061 | Remote Similarity | NPD5175 | Approved |
0.6047 | Remote Similarity | NPD7514 | Phase 3 |
0.6042 | Remote Similarity | NPD5173 | Approved |
0.6024 | Remote Similarity | NPD5275 | Approved |
0.6024 | Remote Similarity | NPD4190 | Phase 3 |
0.6022 | Remote Similarity | NPD7515 | Phase 2 |
0.602 | Remote Similarity | NPD5223 | Approved |
0.6019 | Remote Similarity | NPD4634 | Approved |
0.6 | Remote Similarity | NPD7145 | Approved |
0.6 | Remote Similarity | NPD5141 | Approved |
0.598 | Remote Similarity | NPD7320 | Approved |
0.598 | Remote Similarity | NPD6881 | Approved |
0.598 | Remote Similarity | NPD6899 | Approved |
0.596 | Remote Similarity | NPD7632 | Discontinued |
0.5957 | Remote Similarity | NPD6399 | Phase 3 |
0.5955 | Remote Similarity | NPD3133 | Approved |
0.5955 | Remote Similarity | NPD3665 | Phase 1 |
0.5955 | Remote Similarity | NPD3666 | Approved |
0.5941 | Remote Similarity | NPD4768 | Approved |
0.5941 | Remote Similarity | NPD6920 | Discontinued |
0.5941 | Remote Similarity | NPD4767 | Approved |
0.593 | Remote Similarity | NPD4195 | Approved |
0.5926 | Remote Similarity | NPD7532 | Clinical (unspecified phase) |
0.5926 | Remote Similarity | NPD7327 | Approved |
0.5926 | Remote Similarity | NPD7328 | Approved |
0.5922 | Remote Similarity | NPD6372 | Approved |
0.5922 | Remote Similarity | NPD6373 | Approved |
0.5905 | Remote Similarity | NPD8297 | Approved |
0.59 | Remote Similarity | NPD4754 | Approved |
0.5882 | Remote Similarity | NPD5701 | Approved |
0.5882 | Remote Similarity | NPD5697 | Approved |
0.5876 | Remote Similarity | NPD6083 | Phase 2 |
0.5876 | Remote Similarity | NPD6084 | Phase 2 |
0.5872 | Remote Similarity | NPD7516 | Approved |
0.5865 | Remote Similarity | NPD7290 | Approved |
0.5865 | Remote Similarity | NPD6883 | Approved |
0.5865 | Remote Similarity | NPD7102 | Approved |
0.5862 | Remote Similarity | NPD7332 | Phase 2 |
0.5851 | Remote Similarity | NPD7087 | Discontinued |
0.5849 | Remote Similarity | NPD8133 | Approved |
0.5833 | Remote Similarity | NPD7115 | Discovery |
0.5833 | Remote Similarity | NPD4629 | Approved |
0.5833 | Remote Similarity | NPD5210 | Approved |
0.5825 | Remote Similarity | NPD4730 | Approved |
0.5825 | Remote Similarity | NPD4729 | Approved |
0.5825 | Remote Similarity | NPD5128 | Approved |
0.5824 | Remote Similarity | NPD3574 | Clinical (unspecified phase) |
0.5818 | Remote Similarity | NPD8294 | Approved |
0.5818 | Remote Similarity | NPD8377 | Approved |
0.5814 | Remote Similarity | NPD7322 | Clinical (unspecified phase) |
0.581 | Remote Similarity | NPD6847 | Approved |
0.581 | Remote Similarity | NPD6649 | Approved |
0.581 | Remote Similarity | NPD8130 | Phase 1 |
0.581 | Remote Similarity | NPD6650 | Approved |
0.581 | Remote Similarity | NPD6617 | Approved |
0.581 | Remote Similarity | NPD6869 | Approved |
0.5795 | Remote Similarity | NPD6902 | Approved |
0.5795 | Remote Similarity | NPD6898 | Phase 1 |
0.5778 | Remote Similarity | NPD3668 | Phase 3 |
0.5769 | Remote Similarity | NPD6012 | Approved |
0.5769 | Remote Similarity | NPD6014 | Approved |
0.5769 | Remote Similarity | NPD6013 | Approved |
0.5766 | Remote Similarity | NPD8378 | Approved |
0.5766 | Remote Similarity | NPD8380 | Approved |
0.5766 | Remote Similarity | NPD8296 | Approved |
0.5766 | Remote Similarity | NPD8379 | Approved |
0.5766 | Remote Similarity | NPD8335 | Approved |
0.5766 | Remote Similarity | NPD8033 | Approved |
0.5755 | Remote Similarity | NPD6882 | Approved |
0.5741 | Remote Similarity | NPD6940 | Discontinued |
0.5732 | Remote Similarity | NPD2687 | Approved |
0.5732 | Remote Similarity | NPD2254 | Approved |
0.5732 | Remote Similarity | NPD2686 | Approved |
0.573 | Remote Similarity | NPD4221 | Approved |
0.573 | Remote Similarity | NPD4223 | Phase 3 |
0.5729 | Remote Similarity | NPD7748 | Approved |
0.5714 | Remote Similarity | NPD5250 | Approved |
0.5714 | Remote Similarity | NPD5249 | Phase 3 |
0.5714 | Remote Similarity | NPD5247 | Approved |
0.5714 | Remote Similarity | NPD5251 | Approved |
0.5714 | Remote Similarity | NPD5248 | Approved |
0.5714 | Remote Similarity | NPD5329 | Approved |
0.5701 | Remote Similarity | NPD4632 | Approved |
0.5673 | Remote Similarity | NPD8174 | Phase 2 |
PubChem CID   | 457964 |
ChEMBL   | CHEMBL29711 |
ZINC   |
Molecular Weight:   | 338.25 |
ALogP:   | -1.7346 |
MLogP:   | 3.22 |
XLogP:   | 3.315 |
# Rotatable Bonds:   | 8 |
Polar Surface Area:   | 80.92 |
# H-Bond Aceptor:   | 4 |
# H-Bond Donor:   | 4 |
# Rings:   | 4 |
# Heavy Atoms:   | 24 |